about
TLR7 Gln11Leu single nucleotide polymorphism and susceptibility to cutaneous melanomaPerformance of in silico tools for the evaluation of p16INK4a (CDKN2A) variants in CAGI.CDKN2A unclassified variants in familial malignant melanoma: combining functional and computational approaches for their assessment.Dried blood spot sampling for detection of monoclonal immunoglobulin gene rearrangement.Differences in telomere length between sporadic and familial cutaneous melanoma.BRAF gene copy number and mutant allele frequency correlate with time to progression in metastatic melanoma patients treated with MAPK inhibitors.Association of CDK4 germline and BRAF somatic mutations in a patient with multiple primary melanomas and BRAF inhibitor resistance.Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.Contribution of susceptibility gene variants to melanoma risk in families from the Veneto region of Italy
P50
Q37001734-677F5FE7-6870-4185-BE00-26E0FBFC0CB0Q38691170-5BA43E82-E33B-450E-BBE5-36444F4CCA0BQ39012719-04E7616B-AC53-4279-A462-F3D930D93AD6Q39107171-F02485B0-2B27-428F-8EE6-6CE1280857D0Q51746748-FE8135C8-68B8-4C18-9332-5709F9B17EC5Q52329501-1BBA0957-514B-4AD4-9339-265A07F5C3CBQ54263292-D4D1E51C-7657-433E-A043-5C2343DBB6F7Q55032008-7CD7D9D4-1379-45AA-B960-051B4E26A990Q58486119-9DD753A6-C159-4EB9-9030-B82CAFB18A3D
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lisa Elefanti
@ast
Lisa Elefanti
@en
Lisa Elefanti
@es
Lisa Elefanti
@nl
type
label
Lisa Elefanti
@ast
Lisa Elefanti
@en
Lisa Elefanti
@es
Lisa Elefanti
@nl
prefLabel
Lisa Elefanti
@ast
Lisa Elefanti
@en
Lisa Elefanti
@es
Lisa Elefanti
@nl
P106
P1153
42261197500
P21
P31
P496
0000-0002-6614-7190